Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: ONCOLOGIA, PEDIATRIA, GENÉTICA
ABNT
BASSI, C. L. et al. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients. Brazilian Journal of Medical and Biological Research, v. 37, n. 11, p. 1683-1687, 2004Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2004001100014. Acesso em: 10 nov. 2024.APA
Bassi, C. L., Martelli, L. R., Cipolotti, R., Scrideli, C. A., Defavery, R., & Tone, L. G. (2004). Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients. Brazilian Journal of Medical and Biological Research, 37( 11), 1683-1687. doi:10.1590/s0100-879x2004001100014NLM
Bassi CL, Martelli LR, Cipolotti R, Scrideli CA, Defavery R, Tone LG. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients [Internet]. Brazilian Journal of Medical and Biological Research. 2004 ; 37( 11): 1683-1687.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/s0100-879x2004001100014Vancouver
Bassi CL, Martelli LR, Cipolotti R, Scrideli CA, Defavery R, Tone LG. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients [Internet]. Brazilian Journal of Medical and Biological Research. 2004 ; 37( 11): 1683-1687.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/s0100-879x2004001100014